$ Value
$64K
Shares
2,177
Price
$30
Filed
Feb 27
Insider
Name
Befidi Robert
Title
President, Diagnostics
CIK
0002012361
Roles
Transaction Details
Transaction Date
2026-02-25
Code
F
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
43,327
Footnotes
Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units ("RSU"). | Consists of RSUs that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock. | Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. | This Option will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date.
Filing Info
Befidi Robert's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-25 | NVST | F | $64K |
| 2026-02-25 | NVST | A | $0 |
| 2026-02-25 | NVST | A | $0 |
| 2026-02-25 | NVST | A | $0 |
| 2026-02-01 | NVST | A | $23K |
| 2025-08-25 | NVST | F | $73K |
Other Insiders at NVST (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Hammes Eric D.
Chief Financial Officer
|
— | — | 2026-02-25 |
|
Keel Paul A
Chief Executive Officer
|
— | — | 2026-02-25 |
|
Nance Mark E
General Counsel
|
— | — | 2026-02-25 |
|
Reis Mischa
SVP, Strategy & Bus. Dev.
|
— | $290K | 2026-02-25 |
|
Kaabi Faez C
Chief Accounting Officer
|
— | — | 2026-02-25 |
|
Befidi Robert
President, Diagnostics
|
— | — | 2026-02-25 |
|
Nilsson Stefan
President, Nobel Biocare
|
— | — | 2026-02-25 |
|
Acurio Veronica
President, Orthodontics
|
— | — | 2026-02-25 |